2008
New Developments in Managing Physician-Industry Relationships
Search citation statements
Paper Sections
Select...
45
3
3
0
Citation Types
0
41
0
0
Year Published
2008
2025
Publication Types
Select...
43
5
2
Relationship
1
49
Authors
Journals
Cited by 50 publications
(41 citation statements)
References 5 publications
0
41
0
0
“…Our findings also illustrate the significant interdependence that characterizes the relationship between medical technology companies and healthcare providers, which is at the center of heated debates over potential conflict of interests (Rothman and Chimonas, 2008). In the past few years, there have been significant changes in the policies governing industryphysician relationships and, in many jurisdictions, permissible interactions between these two groups have been restricted (Rothman and Chimonas, 2008;Nakayama, 2010).…”
Section: Ethical Implications Of Online Building Relationshipsmentioning
confidence: 70%
“…Our findings also illustrate the significant interdependence that characterizes the relationship between medical technology companies and healthcare providers, which is at the center of heated debates over potential conflict of interests (Rothman and Chimonas, 2008). In the past few years, there have been significant changes in the policies governing industryphysician relationships and, in many jurisdictions, permissible interactions between these two groups have been restricted (Rothman and Chimonas, 2008;Nakayama, 2010).…”
Section: Ethical Implications Of Online Building Relationshipsmentioning
confidence: 70%
“…Because of concerns about drug representatives having undue influence and biasing physician prescribing behavior in favor of the newest and often more expensive drugs when cheaper alternatives are available, many academic centers and health care systems have restricted physician interactions with drug representatives. 27,28 Thus, general pediatricians who often practice in private solo or group practice settings may have greater access to drug representatives as a source of drug labeling information, whereas such interactions may be more restricted for pediatric subspecialists who often practice in academic centers. 15,[22][23][24][25] Moreover, we found specialty differences in pediatric labeling information sources most likely to influence change in physician prescribing behavior.…”
Section: Discussionmentioning
confidence: 99%
“…In 2006, the American Board of Internal Medicine Foundation and the Institute on Medicine as a Profession set up a taskforce to promote more rigorous Guidelines on physician–industry relationships. This process stimulated heated debate with many similar issues being discussed, such as a decrease in pharmaceutical funding, lack of free samples and no free lunches 21 …”
Section: Discussionmentioning
confidence: 99%
